首页 | 本学科首页   官方微博 | 高级检索  
     

阿托伐他汀对亚临床动脉粥样硬化患者脉搏波传导速度影响的临床观察
引用本文:严丽洁,段红艳,王山岭,李永强,杨海涛,王丽霞. 阿托伐他汀对亚临床动脉粥样硬化患者脉搏波传导速度影响的临床观察[J]. 中原医刊, 2011, 0(24): 1-3
作者姓名:严丽洁  段红艳  王山岭  李永强  杨海涛  王丽霞
作者单位:河南省人民医院老年临床医学部心血管内科,郑州450003
摘    要:目的探讨阿托伐他汀对亚临床动埃及粥样硬化患者脉搏波传导速度(PWV)的影响。方法根据颈动脉内中膜厚度(IMT)将200例研究对象分为亚临床动脉粥样硬化组(n=143,MT≥0.9mm)和对照组(n=57,IMT〈0.9mm),亚临床动脉粥样硬化组随机被分为阿托伐他汀治疗组(n=71)和非阿托伐他汀治疗组(n=72),于0周及8周分别测定脉搏渡传导速度。结果阿托伐他汀能明显降低亚临床动脉粥样硬化组PWV。结论阿托伐他汀能减缓亚临床动脉粥样硬化的进程。

关 键 词:阿托伐他汀  亚临床动脉粥样硬化  脉搏波传导速度

Clinical observation about the influence of atorvastatin on the pulse wave velocity in patients with subclinical atherosclerosis
YAN Li-jie,DUAN Hong-yan,WANG Shah-ling,LI Yong-qiang,YANG Hai-tao,WANG Li-xia. Clinical observation about the influence of atorvastatin on the pulse wave velocity in patients with subclinical atherosclerosis[J]. Central Plains Medical Journal, 2011, 0(24): 1-3
Authors:YAN Li-jie  DUAN Hong-yan  WANG Shah-ling  LI Yong-qiang  YANG Hai-tao  WANG Li-xia
Affiliation:. (Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou 450003, China)
Abstract:Objective To observe the influence of atorvastatin on the pulse wave velocity (PWV) in patients with subclinical atherosclerosis. Methods Two hundred patients were divided into sub - clinical group ( n = 143, IMT ≥0.9mm) , and control group ( n = 57, IMT 〈 0. 9mm) , depending on the carotid intima -media thickness(IMT). Subclinical group was randomly divided into atorvastatin group ( n = 71 ) and nonatorvastatin group (n = 72). The pulse wave velocity in each group was measured at 0 week and 8 week. Results Atorvastatin can reduce PWV in patients with subclinical atherosclerosis. Conclusions Atorvastatin can slow the process of subclinical atherosclerosis.
Keywords:Atorvastatin  Subclinical atherosclerosis  Pulse wave velocity
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号